BE655397A - - Google Patents
Info
- Publication number
- BE655397A BE655397A BE655397DA BE655397A BE 655397 A BE655397 A BE 655397A BE 655397D A BE655397D A BE 655397DA BE 655397 A BE655397 A BE 655397A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US323886A US3274191A (en) | 1963-11-15 | 1963-11-15 | N-(3-aminopyrazinoyl) benzamidines and process for preparing |
Publications (1)
Publication Number | Publication Date |
---|---|
BE655397A true BE655397A (xx) | 1965-05-06 |
Family
ID=23261144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE655397D BE655397A (xx) | 1963-11-15 | 1964-11-06 |
Country Status (11)
Country | Link |
---|---|
US (1) | US3274191A (xx) |
BE (1) | BE655397A (xx) |
BR (1) | BR6464322D0 (xx) |
CH (1) | CH471134A (xx) |
DE (2) | DE1620058A1 (xx) |
DK (1) | DK112736B (xx) |
FR (1) | FR4193M (xx) |
GB (1) | GB1070589A (xx) |
IL (1) | IL22360A (xx) |
NL (1) | NL6413272A (xx) |
SE (1) | SE301152B (xx) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0370987A2 (en) * | 1988-10-21 | 1990-05-30 | Karl H. Beyer, Jr. | Pyrazine derivatives as medicaments for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6501301A (xx) * | 1964-04-03 | 1965-10-04 | ||
US3859287A (en) * | 1971-05-05 | 1975-01-07 | Walter Wesley Parish | Thiopteridines and process for producing same |
US4029657A (en) * | 1976-06-14 | 1977-06-14 | The Dow Chemical Company | 6,7-Dichloro-3,4-dihydro-2H-pyrazino(2,3-B)(1,4)oxazines |
US4208413A (en) * | 1977-03-04 | 1980-06-17 | Merck & Co., Inc. | N-Pyrazinecarbonyl-N'-alkoxycarbonyl and N',N"-bis(alkoxycarbonyl)guanidines and processes for preparing same |
US6858615B2 (en) | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenyl guanidine sodium channel blockers |
US6903105B2 (en) | 2003-02-19 | 2005-06-07 | Parion Sciences, Inc. | Sodium channel blockers |
AR086745A1 (es) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
WO2014099676A1 (en) | 2012-12-17 | 2014-06-26 | Parion Sciences, Inc. | Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration |
NZ709197A (en) | 2012-12-17 | 2020-06-26 | Parion Sciences Inc | 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds |
US9102633B2 (en) | 2013-12-13 | 2015-08-11 | Parion Sciences, Inc. | Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds |
-
1963
- 1963-11-15 US US323886A patent/US3274191A/en not_active Expired - Lifetime
-
1964
- 1964-11-01 IL IL22360A patent/IL22360A/xx unknown
- 1964-11-04 GB GB44964/64A patent/GB1070589A/en not_active Expired
- 1964-11-06 BE BE655397D patent/BE655397A/xx unknown
- 1964-11-11 DE DE19641620058 patent/DE1620058A1/de active Pending
- 1964-11-11 DE DE19641470101 patent/DE1470101A1/de active Pending
- 1964-11-12 CH CH1462064A patent/CH471134A/de not_active IP Right Cessation
- 1964-11-13 BR BR164322/64A patent/BR6464322D0/pt unknown
- 1964-11-13 SE SE13708/64A patent/SE301152B/xx unknown
- 1964-11-13 NL NL6413272A patent/NL6413272A/xx unknown
- 1964-11-14 DK DK563364AA patent/DK112736B/da unknown
-
1965
- 1965-02-12 FR FR5440A patent/FR4193M/fr not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0370987A2 (en) * | 1988-10-21 | 1990-05-30 | Karl H. Beyer, Jr. | Pyrazine derivatives as medicaments for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals |
EP0370987A3 (en) * | 1988-10-21 | 1990-12-19 | Karl H. Beyer, Jr. | Pyrazine derivatives as medicaments for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals |
Also Published As
Publication number | Publication date |
---|---|
NL6413272A (xx) | 1965-05-17 |
DE1620058A1 (de) | 1970-07-23 |
DK112736B (da) | 1969-01-13 |
BR6464322D0 (pt) | 1973-07-26 |
CH471134A (de) | 1969-04-15 |
IL22360A (en) | 1968-07-25 |
DE1470101A1 (de) | 1969-05-29 |
US3274191A (en) | 1966-09-20 |
GB1070589A (en) | 1967-06-01 |
SE301152B (xx) | 1968-05-27 |
FR4193M (xx) | 1966-05-31 |